Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Cash from Operations (2016 - 2025)

Bio-Techne has reported Cash from Operations over the past 17 years, most recently at 82411000.0 for Q4 2025.

  • Quarterly results put Cash from Operations at 82411000.0 for Q4 2025, down 2.29% from a year ago — trailing twelve months through Dec 2025 was 249317000.0 (down 18.18% YoY), and the annual figure for FY2025 was 287556000.0, down 3.82%.
  • Cash from Operations for Q4 2025 was 82411000.0 at Bio-Techne, up from 27585000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for TECH hit a ceiling of 122020000.0 in Q2 2021 and a floor of 27585000.0 in Q3 2025.
  • Median Cash from Operations over the past 5 years was 75181000.0 (2021), compared with a mean of 73654200.0.
  • Biggest five-year swings in Cash from Operations: soared 172.42% in 2021 and later tumbled 56.82% in 2025.
  • Bio-Techne's Cash from Operations stood at 100993000.0 in 2021, then plummeted by 36.25% to 64384000.0 in 2022, then grew by 29.09% to 83116000.0 in 2023, then rose by 1.48% to 84346000.0 in 2024, then fell by 2.29% to 82411000.0 in 2025.
  • The last three reported values for Cash from Operations were 82411000.0 (Q4 2025), 27585000.0 (Q3 2025), and 98201000.0 (Q2 2025) per Business Quant data.